Pfizer (PFE) Reaches Global Agreement with AbbVie (ABBV) on Adalimumab Biosimilar

November 30, 2018 10:01 AM
Pfizer Inc. (NYSE: PFE) today announced that it has signed licensing agreements with AbbVie (Nasdaq: ABBV) , resolving all global ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Litigation Management Comments

Next Articles